Device
sham-CPAP
sham-CPAP is a medical device with 5 clinical trials. Historical success rate of 75.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
100%(3 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_1
1
20%
Ph phase_4
1
20%
Ph not_applicable
3
60%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
3(60.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
60.0%
3 of 5 finished
Non-Completion Rate
40.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(2)
Detailed Status
Completed3
Withdrawn1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (20.0%)
Phase 41 (20.0%)
N/A3 (60.0%)
Trials by Status
withdrawn120%
terminated120%
completed360%
Recent Activity
0 active trials
Showing 5 of 5
completednot_applicable
Sleep Disordered Breathing, Obesity and Pregnancy Study (SOAP)
NCT02086448
terminatednot_applicable
Diabetes-Obstructive Sleep Apnea Treatment Trial
NCT01901055
completedphase_1
Stroke and CPAP Outcome Study: A Sham-controlled Trial of CPAP Among Stroke Rehabilitation Patients
NCT02551757
completedphase_4
Antihypertensive Effect of Continuous Positive Airway Pressure in Resistant Hypertensive Patients With Sleep Apnea
NCT00929175
withdrawnnot_applicable
Continuous Positive Airway Pressure (CPAP) for Fatigue in Patients With Multiple Sclerosis (MS) and Obstructive Sleep Apnea (OSA)
NCT01563900
Clinical Trials (5)
Showing 5 of 5 trials
NCT02086448Not Applicable
Sleep Disordered Breathing, Obesity and Pregnancy Study (SOAP)
NCT01901055Not Applicable
Diabetes-Obstructive Sleep Apnea Treatment Trial
NCT02551757Phase 1
Stroke and CPAP Outcome Study: A Sham-controlled Trial of CPAP Among Stroke Rehabilitation Patients
NCT00929175Phase 4
Antihypertensive Effect of Continuous Positive Airway Pressure in Resistant Hypertensive Patients With Sleep Apnea
NCT01563900Not Applicable
Continuous Positive Airway Pressure (CPAP) for Fatigue in Patients With Multiple Sclerosis (MS) and Obstructive Sleep Apnea (OSA)
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5